1066
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 4
HEMATOLOGICAL STUDIES IN LIVER CIRRHOSIS
Xalimova Yulduz Saloxiddinovna
Asia Internatoinal University
https://doi.org/10.5281/zenodo.15242474
Abstract
. Liver cirrhosis is a chronic and progressive condition marked by fibrosis and
nodular regeneration of hepatic tissue, ultimately leading to hepatic failure. Besides the direct
effects on liver structure and function, cirrhosis has systemic implications, particularly in
hematological homeostasis. Hematological abnormalities are frequently observed in cirrhotic
patients and may serve as markers of disease progression and complications. This article
provides a comprehensive overview of hematological disturbances in liver cirrhosis, their
underlying mechanisms, diagnostic tools, and clinical relevance in patient management.
Keywords:
structure, chronic viral hepatitis, the synthesis of clotting factors, non-
alcoholic steatohepatitis (NASH), synthetic.
ГЕМАТОЛОГИЧЕСКИЕ ИССЛЕДОВАНИЯ ПРИ ЦИРРОЗЕ ПЕЧЕНИ
Аннотация.
Цирроз печени — хроническое и прогрессирующее заболевание,
характеризующееся фиброзом и узелковой регенерацией печеночной ткани, что в
конечном итоге приводит к печеночной недостаточности. Помимо прямого воздействия
на структуру и функцию печени, цирроз имеет системные последствия, особенно в
гематологическом гомеостазе. Гематологические нарушения часто наблюдаются у
пациентов с циррозом и могут служить маркерами прогрессирования заболевания и
осложнений. В этой статье представлен всесторонний обзор гематологических
нарушений при циррозе печени, их основных механизмов, диагностических инструментов
и клинической значимости в лечении пациентов.
Ключевые слова:
структура, хронический вирусный гепатит, синтез факторов
свертывания, неалкогольный стеатогепатит (НАСГ), синтетический.
Introduction
Liver cirrhosis constitutes the final and irreversible phase of various chronic liver
diseases, including alcoholic liver disease, chronic viral hepatitis, non-alcoholic steatohepatitis
(NASH), and autoimmune hepatitis. As the disease progresses, normal hepatic architecture is
replaced by fibrous tissue and regenerative nodules, severely impairing the liver’s ability to
perform essential metabolic, synthetic, and detoxifying functions.
The hematological system is particularly sensitive to changes in liver function. The liver
plays a crucial role in hematopoiesis, iron storage, the synthesis of clotting factors, and
regulation of platelet production through thrombopoietin. Consequently, liver dysfunction results
1067
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 4
in a broad range of hematological abnormalities that include anemia, thrombocytopenia,
leukopenia, and coagulopathies. Recognizing and managing these complications is fundamental
to the treatment of patients with cirrhosis.
1. Anemia in Liver Cirrhosis
Anemia affects approximately 75% of patients with decompensated cirrhosis and can
significantly impact quality of life and clinical outcomes. The pathogenesis of anemia in
cirrhosis is multifactorial and includes:
Chronic gastrointestinal bleeding
, particularly from esophageal and gastric varices,
portal hypertensive gastropathy, or hemorrhoids.
Hypersplenism
, which results in the increased destruction of erythrocytes due to
splenomegaly and blood cell sequestration.
Nutritional deficiencies
, such as iron, folate, and vitamin B12, which are common in
alcoholics and malnourished individuals.
Bone marrow suppression
due to alcohol toxicity or chronic inflammation.
Hemolytic anemia
, such as spur cell anemia in advanced liver disease, where altered
lipid metabolism changes the erythrocyte membrane.
Clinically, anemia may be asymptomatic or present with fatigue, pallor, and reduced
exercise tolerance. Laboratory evaluation includes complete blood count (CBC), reticulocyte
count, iron studies, and vitamin levels. Treatment is based on the underlying cause: iron or
vitamin supplementation, blood transfusions, or control of variceal bleeding.
2. Thrombocytopenia
Thrombocytopenia is one of the earliest and most consistent hematologic findings in liver
cirrhosis. Platelet counts often drop below 150,000/μL, and severe thrombocytopenia
(<50,000/μL) is observed in advanced stages.
Etiology:
Splenic sequestration
due to portal hypertension results in pooling and destruction of
platelets.
Decreased hepatic production of thrombopoietin (TPO)
, a key regulator of platelet
production.
Bone marrow suppression
by alcohol or infections (e.g., hepatitis C virus).
Autoimmune mechanisms
, including the presence of antiplatelet antibodies in some
cirrhotic patients.
Clinical significance:
Thrombocytopenia increases the risk of spontaneous mucosal bleeding, complicates
invasive diagnostic or therapeutic procedures (e.g., liver biopsy, paracentesis), and may delay
1068
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 4
antiviral or chemotherapy treatments. In cases of severe thrombocytopenia, platelet transfusions
or thrombopoietin receptor agonists (e.g., eltrombopag, avatrombopag) may be required.
3. Leukopenia
Leukopenia, particularly neutropenia, is often seen in cirrhosis, particularly in the context
of hypersplenism. While mild leukopenia may be asymptomatic, significant reductions can
impair host defense mechanisms and increase susceptibility to infections such as spontaneous
bacterial peritonitis (SBP), pneumonia, and urinary tract infections.
In cirrhotic patients with leukopenia, clinicians should remain vigilant for signs of sepsis,
especially in hospitalized or immunocompromised individuals. Management includes infection
prophylaxis (e.g., norfloxacin in SBP prevention) and addressing splenomegaly or bone marrow
suppression.
4. Coagulopathy and Hemostatic Imbalance
The liver is the primary site for the synthesis of most coagulation factors (except factor
VIII and von Willebrand factor). In cirrhosis, impaired hepatic synthetic function results in:
Reduced levels of clotting factors
(factors II, V, VII, IX, and X).
Diminished synthesis of anticoagulant proteins
(antithrombin, protein C, and protein
S).
Prolonged prothrombin time (PT)
and
elevated international normalized ratio
(INR)
.
Historically, cirrhosis was viewed as a hypocoagulable state. However, recent studies
show that patients may also have
a prothrombotic tendency
, particularly due to elevated levels
of factor VIII and reduced levels of natural anticoagulants. As a result, cirrhosis is now
considered a
“rebalanced” hemostatic state
, where both bleeding and thrombosis can occur.
Clinical implications:
Increased risk of gastrointestinal bleeding and hemorrhagic complications.
Paradoxically, risk of
portal vein thrombosis
or
deep vein thrombosis
.
Routine use of fresh frozen plasma (FFP) for prophylactic correction of INR is not
recommended unless active bleeding is present or procedures are planned.
5. Diagnostic Tools and Laboratory Assessment
Thorough hematologic evaluation is critical in all cirrhotic patients. Recommended tests
include:
CBC
: to assess for anemia, leukopenia, and thrombocytopenia.
Peripheral blood smear
: may show spur cells, macrocytosis, or evidence of hemolysis.
Iron studies
: serum iron, ferritin, transferrin saturation.
Vitamin B12 and folate levels
.
1069
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 4
Coagulation profile
: PT, INR, activated partial thromboplastin time (aPTT), fibrinogen.
Thrombopoietin levels
(if available).
Liver and spleen ultrasound
: to assess for splenomegaly and portal hypertension.
Bone marrow biopsy
: indicated if pancytopenia or hematological malignancy is
suspected.
6. Therapeutic Considerations
Treatment of hematologic abnormalities in cirrhosis is based on etiology and severity:
Anemia
: iron supplementation (oral or IV), erythropoiesis-stimulating agents (rarely),
blood transfusions, and control of bleeding sources.
Thrombocytopenia
: platelet transfusions, TPO receptor agonists, splenectomy in
refractory cases (rare).
Leukopenia
: infection prophylaxis, granulocyte colony-stimulating factor (G-CSF) in
select cases.
Coagulopathy
: vitamin K (if deficiency is suspected), FFP for active bleeding,
antifibrinolytics, or anticoagulation therapy if thrombosis is present.
Importantly,
liver transplantation
remains the definitive treatment for end-stage liver
disease and can reverse many of the hematological abnormalities over time.
Conclusion
Hematological disturbances are common in patients with liver cirrhosis and reflect
complex pathophysiological processes involving hypersplenism, impaired liver synthesis,
nutritional deficiencies, and altered bone marrow function. These abnormalities not only
contribute to the morbidity and mortality of cirrhosis but also influence treatment strategies and
prognosis.
Comprehensive hematological assessment should be incorporated into the routine
evaluation of cirrhotic patients. Understanding the dynamic balance between bleeding and
thrombosis, recognizing the risk of infection due to leukopenia, and identifying correctable
causes of anemia are essential for effective clinical management. Interdisciplinary collaboration
among hepatologists, hematologists, and critical care specialists is vital to optimize patient
outcomes.
REFERENCES
1.
Schuppan D, Afdhal NH. Liver cirrhosis.
Lancet
. 2008;371(9615):838–851.
2.
Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis.
Lancet
. 2014;383(9930):1749–
1761.
3.
Qamar AA, Grace ND. Thrombocytopenia in chronic liver disease.
Clin Liver Dis
.
1070
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 4
2009;13(1):43–58.
4.
Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease.
N Engl J Med
.
2011;365(2):147–156.
5.
McHutchison JG, Bacon BR. Anemia and its management in chronic liver disease.
Hepatology
. 2006;44(2):513–520.
6.
Халимова, Ю. С. (2021). MORPHOFUNCTIONAL ASPECTS OF THE HUMAN
BODY IN THE ABUSE OF ENERGY DRINKS.
Новый день в медицине
,
5
(37), 208-
210.
7.
Халимова, Ю. С. (2022). МОРФОФУНКЦИОНАЛЬНЫЕ ОСОБЕННОСТИ
ЯИЧНИКОВ
КРЫС
ПРИ
ВОЗДЕЙСТВИИ
КОФЕИН
СОДЕРЖАЩИХ
НАПИТОК.
Gospodarka i Innowacje.
,
23
, 368-374.
8.
Salokhiddinovna, X. Y. (2023). INFLUENCE OF EXTERNAL FACTORS ON THE
MALE
REPRODUCTIVE
SYSTEM.
EUROPEAN
JOURNAL
OF
MODERN
MEDICINE AND PRACTICE
,
3
(10), 6-13.
9.
Халимова, Ю. С., & Шокиров, Б. С. (2022). МОРФОФУНКЦИОНАЛЬНЫЕ
ООБЕННОСТИ
ВНУТРЕННИХ
ОРГАНОВ
ПРИ
ХРОНИЧЕСКОМ
АЛКОГОЛИЗМЕ.
Scientific progress
,
3
(2), 782-789.
10.
Halimova, Y. S. (2023). Morphological Aspects of Rat Ovaries When Exposed to
Caffeine Containing Drink.
BEST JOURNAL OF INNOVATION IN SCIENCE,
RESEARCH AND DEVELOPMENT
,
2
(6), 294-300.
11.
Halimova, Y. S., Shokirov, B. S., & Khasanova, D. A. (2023). Reproduction and
Viability of Female Rat Offspring When Exposed To Ethanol.
Procedia of Engineering
and Medical Sciences
, 32-35.
12.
Salokhiddinovna, H. Y. (2023). Morphological Features of the Human Body in Energy
Drink
Abuse.
EUROPEAN
JOURNAL OF INNOVATION IN NONFORMAL
EDUCATION
,
3
(5), 51-53.
13.
Халимова, Ю. С., & Шокиров, Б. С. (2022). СОВРЕМЕННЫЕ ДАННЫЕ О
МОРФО-ФУНКЦИОНАЛЬНЫХ АСПЕКТОВ ЧЕЛОВЕЧЕСКОГО ОРГАНИЗМА
ПРИ ЗЛОУПОТРЕБЛЕНИЕ ЭНЕРГЕТИЧЕСКИМИ НАПИТКАМИ.
PEDAGOGS
jurnali
,
4
(1), 154-161.
14.
Halimova, Y. S. (2023). Morphofunctional Aspects of Internal Organs in Chronic
Alcoholism.
AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI
,
2
(5), 83-87.
15.
Shokirov, B. S. (2021). Halimova Yu. S. Antibiotic-induced rat gut microbiota dysbiosis
and salmonella resistance Society and innovations.
1071
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 4
16.
Халимова, Ю. С., & Шокиров, Б. С. (2021). Репродуктивность и жизнеспособность
потомства самок крыс при различной длительности воздействия этанола.
In
Актуальные вопросы современной медицинской науки и здравоохранения:
Материалы VI Международной научно-практической конференции молодых
учёных и студентов, посвященной году науки и технологий,(Екатеринбург, 8-9
апреля 2021): в 3-х т.
. Федеральное государственное бюджетное образовательное
учреждение высшего образования «Уральский государственный медицинский
университет» Министерства здравоохранения Российской Федерации.
17.
Khalimova, Y. S. BS Shokirov Morphological changes of internal organs in chronic
alcoholism.
Middle European scientific bulletin
, 12-2021.
18.
Шокиров, Б. С., & Халимова, Ю. С. (2022). ДИСБИОЗ ВЫЗВАННЫЙ
АНИБИОТИКАМИ КИШЕЧНОЙ МИКРОБИОТЫ КРЫС И УСТОЙЧИВОСТЬ К
САЛМОНЕЛЛАМ.
Scientific progress
,
3
(2), 766-772.
19.
Salokhiddinovna, X. Y. (2023). Clinical Features of the Course of Vitamin D Deficiency
in Women of Reproductive Age.
EUROPEAN JOURNAL OF INNOVATION IN
NONFORMAL EDUCATION
,
3
(11), 28-31.
20.
Шокиров, Б., & Халимова, Ю. (2021). Антибиотик-индуцированный дисбиоз
микробиоты кишечника крыс и резистентность к сальмонеллам.
Общество и
инновации
,
2
(4/S), 93-100.
21.
Salokhiddinovna, X. Y. (2023). MORPHOLOGICAL CHANGES IN PATHOLOGICAL
FORMS OF ERYTHROCYTES.
EUROPEAN JOURNAL OF MODERN MEDICINE
AND PRACTICE
,
3
(11), 20-24.
22.
Saloxiddinovna, X. Y. (2023). ERITROTSITLAR PATOLOGIK SHAKLLARINING
MORFOLOGIK O'ZGARISHLARI.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ
ИДЕИ В МИРЕ
,
33
(1), 167-172.
23.
Шокиров, Б., & Халимова, Ю. (2021). Antibiotic-induced rat gut microbiota dysbiosis
and salmonella resistance.
Общество и инновации
,
2
(4/S), 93-100.
24.
Шокиров, Б. С., & Халимова, Ю. С. (2021). Пищеварительная функция кишечника
после коррекции экспериментального дисбактериоза у крыс бифидобактериями.
In
Актуальные вопросы современной медицинской науки и здравоохранения:
Материалы VI Международной научно-практической конференции молодых
учёных и студентов, посвященной году науки и технологий,(Екатеринбург, 8-9
апреля 2021): в 3-х т.
. Федеральное государственное бюджетное образовательное
учреждение высшего образования «Уральский государственный медицинский
университет» Министерства здравоохранения Российской Федерации.
1072
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 4
25.
Salokhiddinovna, X. Y. (2023). Anemia of Chronic Diseases.
Research Journal of
Trauma and Disability Studies
,
2
(12), 364-372.
26.
Salokhiddinovna, X. Y. (2023). MALLORY WEISS SYNDROME IN DIFFUSE LIVER
LESIONS.
Journal of Science in Medicine and Life
,
1
(4), 11-15.
27.
Salohiddinovna, X. Y. (2023). SURUNKALI KASALLIKLARDA UCHRAYDIGAN
ANEMIYALAR MORFO-FUNKSIONAL XUSUSIYATLARI.
Ta'lim innovatsiyasi va
integratsiyasi
,
10
(3), 180-188.
28.
Халимова, Ю. С. (2024). КЛИНИКО-МОРФОЛОГИЧЕСКИЕ ОСОБЕННОСТИ
ВИТАМИНА
D
В
ФОРМИРОВАНИЕ
ПРОТИВОИНФЕКЦИОННОГО
ИММУНИТА.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
36
(3), 86-94.
29.
Saloxiddinovna, X. Y. (2024). CLINICAL FEATURES OF VITAMIN D EFFECTS ON
BONE METABOLISM.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
36
(5), 90-99.
30.
Saloxiddinovna, X. Y. (2024). CLINICAL AND MORPHOLOGICAL ASPECTS OF
AUTOIMMUNE THYROIDITIS.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ
ИДЕИ В МИРЕ
,
36
(5), 100-108.
31.
Saloxiddinovna, X. Y. (2024). MORPHOFUNCTIONAL FEATURES BLOOD
MORPHOLOGY IN AGE-RELATED CHANGES.
Лучшие интеллектуальные
исследования
,
14
(4), 146-158.
32.
Saloxiddinovna, X. Y. (2024). CLINICAL MORPHOLOGICAL CRITERIA OF
LEUKOCYTES.
Лучшие интеллектуальные исследования
,
14
(4), 159-167.
33.
Saloxiddinovna, X. Y. (2024). Current Views of Vitamin D Metabolism in the Body.
Best
Journal of Innovation in Science, Research and Development
,
3
(3), 235-243.
34.
Saloxiddinovna, X. Y. (2024). MORPHOFUNCTIONAL FEATURES OF THE
STRUCTURE AND DEVELOPMENT OF THE OVARIES.
EUROPEAN JOURNAL
OF MODERN MEDICINE AND PRACTICE
,
4
(4), 220-227.
35.
Saloxiddinovna, X. Y. (2024). Modern Views on the Effects of the Use of Cholecalciferol
on the General Condition of the Bod.
JOURNAL OF HEALTHCARE AND LIFE-
SCIENCE RESEARCH
,
3
(5), 79-85.
36.
Халимова, Ю. С., & Хафизова, М. Н. (2024). МОРФО-ФУНКЦИОНАЛЬНЫЕ И
КЛИНИЧЕСКИЕ АСПЕКТЫ СТРОЕНИЯ И РАЗВИТИЯ ЯИЧНИКОВ (ОБЗОР
ЛИТЕРАТУРЫ).
TADQIQOTLAR. UZ
,
40
(5), 188-198.
1073
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 4
37.
Халимова, Ю. С. (2024). Морфологические Особенности Поражения Печени У
Пациентов С Синдромом Мэллори-Вейса.
Journal of Science in Medicine and
Life
,
2
(6), 166-172.
38.
Xalimova, Y. S. (2024). Morphology of the Testes in the Detection of Infertility.
Journal
of Science in Medicine and Life
,
2
(6), 83-88.
39.
KHALIMOVA, Y. S. (2024). MORPHOFUNCTIONAL CHARACTERISTICS OF
TESTICULAR AND OVARIAN TISSUES OF ANIMALS IN THE AGE
ASPECT.
Valeology: International Journal of Medical Anthropology and Bioethics
,
2
(9),
100-105.
40.
Salokhiddinovna, K. Y. (2024). IMMUNOLOGICAL CRITERIA OF REPRODUCTION
AND VIABILITY OF FEMALE RAT OFFSPRING UNDER THE INFLUENCE OF
ETHANOL.
EUROPEAN
JOURNAL
OF
MODERN
MEDICINE
AND
PRACTICE
,
4
(10), 200-205.
41.
Salokhiddinovna, K. Y., Saifiloevich, S. B., Barnoevich, K. I., & Hikmatov, A. S. (2024).
THE INCIDENCE OF AIDS, THE DEFINITION AND CAUSES OF THE
DISEASE.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
55
(2),
195-205.
42.
Nematilloevna, K. M., & Salokhiddinovna, K. Y. (2024). IMPORTANT FEATURES IN
THE FORMATION OF DEGREE OF COMPARISON OF ADJECTIVES IN
LATIN.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
55
(2),
150-157.
43.
Saloxiddinovna, X. Y., & Ne’matillaevna, X. M. (2024). FEATURES OF THE
STRUCTURE OF THE REPRODUCTIVE ORGANS
OF THE FEMALE
BODY.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
55
(2),
179-183.
44.
Хафизова, М. Н., & Халимова, Ю. С. (2024). ИСПОЛЬЗОВАНИЕ ЧАСТОТНЫХ
ОТРЕЗКОВ В НАИМЕНОВАНИЯХ ЛЕКАРСТВЕННЫХ ПРЕПАРАТОВ В
ФАРМАЦЕВТИКЕ.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
55
(2), 172-178.
45.
Хафизова, М. Н., & Халимова, Ю. С. (2024). МОТИВАЦИОННЫЕ МЕТОДЫ ПРИ
ОБУЧЕНИИ ЛАТЫНИ И МЕДИЦИНСКОЙ ТЕРМИНОЛОГИИ.
ОБРАЗОВАНИЕ
НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
55
(2), 165-171.
46.
Халимова, Ю. С., & Хафизова, М. Н. (2024). ОСОБЕННОСТИ СОЗРЕВАНИЕ И
ФУНКЦИОНИРОВАНИЕ
ЯИЧНИКОВ.
ОБРАЗОВАНИЕ
НАУКА
И
ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
55
(2), 188-194.
1074
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 4
47.
Халимова, Ю. С., & Хафизова, М. Н. (2024). КЛИНИЧЕСКИЕ АСПЕКТЫ ЛИЦ
ЗЛОУПОТРЕБЛЯЮЩЕЕСЯ
ЭНЕРГЕТИЧЕСКИМИ
НАПИТКАМИ.
TADQIQOTLAR. UZ
,
40
(5), 199-207.
48.
Халимова, Ю. С., & Хафизова, М. Н. (2024). кафедра Клинических наук Азиатский
международный университет Бухара, Узбекистан.
Modern
education
and
development
,
10
(1), 60-75.
49.
Халимова, Ю. С., & Хафизова, М. Н. (2024). КЛИНИЧЕСКИЕ ОСОБЕННОСТИ
ЗАБОЛЕВАНИЙ ВНУТРЕННИХ ОРГАНОВ У ЛИЦ, СТРАДАЮЩИХ
АЛКОГОЛЬНОЙ ЗАВИСИМОСТЬЮ.
TADQIQOTLAR. UZ
,
40
(5), 240-250.
50.
Халимова, Ю. С., & Хафизова, М. Н. (2024). МОРФО-ФУНКЦИОНАЛЬНЫЕ И
КЛИНИЧЕСКИЕ АСПЕКТЫ ФОРМИРОВАНИЯ КОЖНЫХ ПОКРОВОВ.
Modern
education and development
,
10
(1), 76-90.
51.
Khalimova, Y. S. (2024). Features of Sperm Development: Spermatogenesis and
Fertilization.
American Journal of Bioscience and Clinical Integrity
,
1
(11), 90-98.
52.
Salokhiddinovna, K. Y., & Nematilloevna, K. M. (2024). MODERN MORPHOLOGY
OF HEMATOPOIETIC ORGANS.
Modern education and development
,
16
(9), 50-60.
53.
Khalimova, Y. (2025). MORPHOLOGY OF PATHOLOGICAL FORMS OF
PLATELETS.
Modern Science and Research
,
4
(2), 749-759.
54.
Salokhiddinovna, K. Y., & Nematilloevna, K. M. (2025). MODERN MORPHOLOGY
OF HEMATOPOIETIC ORGANS.
Modern education and development
,
19
(2), 498-508.
55.
Халимова, Ю. С., & Хафизова, М. Н. (2025). СОВРЕМЕННАЯ МОРФОЛОГИЯ
КРОВЕТВОРНЫХ ОРГАНОВ.
Modern education and development
,
19
(2), 487-497.
56.
Халимова, Ю. С., & Хафизова, М. Н. (2025). ГИСТОЛОГИЧЕСКАЯ
СТРУКТУРНАЯ
МОРФОЛОГИЯ
НЕФРОНОВ.
Modern
education
and
development
,
19
(2), 464-475.
57.
Saloxiddinovna, X. Y., & Nematilloevna, X. M. (2025). NEFRONLARNING
GISTOLOGIK
TUZILISH
MORFOLOGIYASI.
Modern
education
and
development
,
19
(2), 509-520.
58.
Saloxiddinovna, X. Y., & Ne’matilloyevna, X. M. (2025). QON YARATUVCHI
A'ZOLARNING
ZAMONAVIY
MORFOLOGIYASI.
Modern
education
and
development
,
19
(2), 476-486.
59.
Xalimova, Y. (2025). MODERN CONCEPTS OF BIOCHEMISTRY OF BLOOD
COAGULATION.
Modern Science and Research
,
4
(3), 769-777.
